Teva Pharmaceuticals slammed with €462.6m fine for blocking Copaxone competitors
Teva Pharmaceuticals, the generics powerhouse, has been slapped with a hefty fine of €462.6 million by the European Commission for anti-competitive practices related to its ... Read More
Servier closes acquisition of Danish antibody discovery company Symphogen
Servier has wrapped up its previously announced acquisition of Symphogen, a Danish antibody discovery company, for an undisclosed price. The French pharma company signed the ... Read More
Servier to acquire Danish antibody discovery company Symphogen
Servier acquisition of Symphogen : French pharma company Servier has agreed to acquire Danish antibody discovery company Symphogen, for an undisclosed price to boost its ... Read More
Pixuvri EMA approval : Servier NHL drug secures standard marketing authorization in Europe
Pixuvri EMA approval : French pharma company Servier has secured full approval for Pixuvri (pixantrone) from the European Commission (EC) as monotherapy for aggressive non-Hodgkin ... Read More
FDA clears Servier and Pfizer for clinical development of UCART19 for acute lymphoblastic leukemia
Servier and Pfizer Inc. have received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) to proceed with the clinical development ... Read More